Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor
ClinicalTrials.gov NCT05216250
Research payments
$5,607,923
Through program year 2025, $5,607,923 in research payments was reported against Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor, across 902 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT05216250
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $322,961 | 99 |
| 2024 | Research | $2,809,929 | 371 |
| 2023 | Research | $1,836,142 | 315 |
| 2022 | Research | $638,890 | 117 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Martin Taylor New Albany, OH Named on 42 payments
- Christine Cooper Charleston, SC Named on 38 payments
- Rajesh Pahwa Kansas City, KS Named on 35 payments
- Khashayar Dashtipour Loma Linda, CA Named on 32 payments
- Ramon Rodriguez Orlando, FL Named on 31 payments
- Diane Counce Birmingham, AL Named on 29 payments
- Atul Patel Overland Park, KS Named on 29 payments
- Jeanne Feuerstein Aurora, CO Named on 29 payments
- Nicki Niemann Phoenix, AZ Named on 27 payments
- Stuart Isaacson Boca Raton, FL Named on 27 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.